Skip to main content
. 2021 Jan 26;22(3):1204. doi: 10.3390/ijms22031204

Figure 6.

Figure 6

FAAH inhibitor JZP327A reduces basal FAAH activity in vitro at the cortical level. Data is from ABPP testing of the frontal cortex (FC), temporal cortex (TC) and occipital cortex (OC) proteomes incubated for 1 h with vehicle (DMSO) and the specific FAAH inhibitor JZP327A (1 μM). Notice that JZP327A reduced FAAH activity by 72% in FC, 67% in TC and 78% in OC. One-way ANOVA with Tukey’s multiple comparison post-hoc test was used for comparison, *** p < 0.001, n = 9.